![]() | Esser, N., Mongovin, S. M., Parilla, J., Barrow, B. M., Mundinger, T. O., Fountaine, B. S., Larmore, M. J., Castillo, J. J., Akter, R., Hull, R. L., & Zraika, S. (01 March 2022). Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with β-cell dysfunction. American Journal of Physiology - Endocrinology and Metabolism, 322 (3), 307-E318. doi:10.1152/ajpendo.00234.2021 Peer Reviewed verified by ORBi |
![]() | Kahn, S. E., Chen, Y.-C., Esser, N., Taylor, A. J., van Raalte, D. H., Zraika, S., & Verchere, C. B. (2021). The β Cell in Diabetes: Integrating Biomarkers With Functional Measures. Endocrine Reviews, 42 (5), 528-583. doi:10.1210/endrev/bnab021 Peer Reviewed verified by ORBi |
![]() | Esser, N., Utzschneider, K. M., & Kahn, S. E. (2020). Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. Diabetologia, 63 (10), 2007-2021. doi:10.1007/s00125-020-05245-x Peer Reviewed verified by ORBi |
![]() | ESSER, N., Legrand, S., Piette, J., SCHEEN, A., & PAQUOT, N. (2014). Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Research and Clinical Practice. doi:10.1016/j.diabres.2014.04.006 Peer Reviewed verified by ORBi |
![]() | ESSER, N., L'Homme, L., DE ROOVER, A., KOHNEN, L., SCHEEN, A., MOUTSCHEN, M., Piette, J., Legrand-Poels, S., & PAQUOT, N. (November 2013). Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue. Diabetologia, 56, 2487-2497. doi:10.1007/s00125-013-3023-9 Peer Reviewed verified by ORBi |